ResMed
656 hedge funds and large institutions have $13B invested in ResMed in 2023 Q3 according to their latest regulatory filings, with 60 funds opening new positions, 248 increasing their positions, 252 reducing their positions, and 123 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
37% less capital invested
Capital invested by funds: $20.8B → $13B (-$7.8B)
51% less first-time investments, than exits
New positions opened: 60 | Existing positions closed: 123
Holders
656
Holding in Top 10
8
Calls
$115M
Puts
$93.7M
Top Buyers
| 1 | +$213M | |
| 2 | +$129M | |
| 3 | +$110M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$86.5M |
| 5 |
D.E. Shaw & Co
New York
|
+$84.1M |
Top Sellers
| 1 | -$769M | |
| 2 | -$413M | |
| 3 | -$379M | |
| 4 |
OCBV
Ownership Capital B.V.
Amsterdam,
Netherlands
|
-$330M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$132M |